Articles from CONMED Corporation

CONMED Corporation (NYSECNMD) today announced that Mark Kaye will be joining its Board of Directors effective February 24th, 2025.

CONMED Corporation (NYSECNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on February 24, 2025, payable on April 4, 2025, to all shareholders of record as of March 14, 2025.

CONMED Corporation (NYSECNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2024.

CONMED Corporation (NYSECNMD) today announced that it will report financial results for the fourth quarter 2024 after the market close on Wednesday, February 5, 2025. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.

CONMED Corporation (NYSECNMD) today announced that Patrick J. Beyer, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the J.P. Morgan Healthcare Conference at 4:30 p.m. PT (7:30 p.m. ET) on Monday, January 13, 2025 in San Francisco, CA.

CONMED Corporation (NYSECNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on December 9, 2024, payable on January 3, 2025, to all shareholders of record as of December 20, 2024.

CONMED Corporation (NYSECNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, Todd W. Garner, Executive Vice President and Chief Financial Officer, and Pat J. Beyer, Chief Operating Officer, will participate in a fireside chat at the Piper Sandler Healthcare Conference at 12:30 p.m. ET on Tuesday, December 3, 2024.

CONMED Corporation (NYSECNMD) today announced that it will participate in fireside chats at the following two investor conferences in November:

CONMED Corporation (NYSECNMD) today announced financial results for the third quarter ended September 30, 2024.

CONMED Corporation (NYSECNMD) today announced that Curt R. Hartman will retire as President and Chief Executive Officer (CEO) of the Company, effective January 1, 2025. Patrick Beyer, current Chief Operating Officer (COO) of CONMED, will succeed Mr. Hartman as President and CEO and will also be appointed as a member of the Company’s board, effective the same date.

As a follow up to the Current Report on Form 8-K issued by the Company on September 30, 2024, CONMED Corporation (NYSECNMD) announced preliminary financial information for the third quarter of 2024. The Company expects revenue in the range of $315 million to $318 million and adjusted diluted net earnings per share growth in excess of its previously provided guidance of 9% to 11%.

CONMED Corporation (NYSECNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at the CL King 22nd Annual Best Ideas Conference at 10:15 a.m. ET on Monday, September 16, 2024.

CONMED Corporation (NYSECNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Wells Fargo Healthcare Conference at 8:00 a.m. ET on Wednesday, September 4, 2024.

CONMED Corporation (NYSECNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on August 8, 2024, payable on October 4, 2024, to all shareholders of record as of September 16, 2024.

CONMED Corporation (NYSECNMD) today announced financial results for the second quarter ended June 30, 2024.

CONMED Corporation (NYSECNMD) today announced it will report financial results for the second quarter of 2024 after the market close on Wednesday, July 31, 2024. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.

CONMED Corporation (NYSECNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference at 8:00 a.m. ET on Thursday, June 6, 2024.

CONMED Corporation (NYSECNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on May 22, 2024, payable on July 5, 2024, to all shareholders of record as of June 14, 2024.

CONMED Corporation (NYSECNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, Todd W. Garner, Executive Vice President and Chief Financial Officer, and Pat Beyer, Chief Operating Officer, will present at the BofA Securities Healthcare Conference at 2:20 p.m. PT (5:20 p.m. ET) on Tuesday, May 14, 2024 in Las Vegas, NV.

CONMED Corporation (NYSECNMD) today announced that Patrick Beyer, President of International and Global Orthopedics, has been promoted to the newly created role of Chief Operating Officer (COO), effective immediately. In this role, Mr. Beyer will take on additional responsibility for leading the Company’s commercial businesses, as well as Operations, Distribution, Regulatory Affairs / Quality Assurance, and Customer Excellence.

CONMED Corporation (NYSECNMD) today announced financial results for the first quarter ended March 31, 2024.

CONMED Corporation (NYSECNMD) today announced that it will report financial results for the first quarter 2024 after the market close on Wednesday, April 24, 2024. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.

CONMED Corporation (NYSECNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on February 26, 2024, payable on April 5, 2024, to all shareholders of record as of March 15, 2024.

CONMED Corporation (NYSECNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2023.

CONMED Corporation (NYSECNMD) today announced that it will report financial results for the fourth quarter 2023 after the market close on Wednesday, January 31, 2024. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.

CONMED Corporation (NYSECNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the J.P. Morgan Healthcare Conference at 2:15 p.m. PT (5:15 p.m. ET) on Monday, January 8, 2024 in San Francisco, CA.

CONMED Corporation (NYSECNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on December 4, 2023, payable on January 5, 2024, to all shareholders of record as of December 18, 2023.

CONMED Corporation (NYSECNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Piper Sandler Healthcare Conference at 9:00 a.m. ET on Tuesday, November 28, 2023.

CONMED Corporation (NYSECNMD) today announced that it will participate in fireside chats at the following two investor conferences in November:

CONMED Corporation (NYSECNMD) today announced financial results for the third quarter ended September 30, 2023.

CONMED Corporation (NYSECNMD) today announced that it will report financial results for the third quarter 2023 after the market close on Wednesday, October 25, 2023. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.

CONMED Corporation (NYSECNMD) today announced that Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at the CL King 21st Annual Best Ideas Conference at 10:15 a.m. ET on Monday, September 18, 2023.

CONMED Corporation (NYSECNMD) today announced that Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Wells Fargo Healthcare Conference at 2:15 p.m. ET on Thursday, September 7, 2023.

CONMED Corporation (NYSECNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on October 5, 2023, to all shareholders of record as of September 15, 2023. 

CONMED Corporation (NYSECNMD) today announced financial results for the second quarter ended June 30, 2023.

CONMED Corporation (NYSECNMD) today announced that it will report financial results for the second quarter 2023 after the market close on Wednesday, July 26, 2023. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.

CONMED Corporation (NYSECNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Jefferies Healthcare Conference at 10:00 a.m. ET on Thursday, June 8, 2023.

CONMED Corporation (NYSECNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on July 5, 2023, to all shareholders of record as of June 15, 2023.

CONMED Corporation (NYSECNMD) today announced financial results for the first quarter ended March 31, 2023.

CONMED Corporation (NYSECNMD) today announced that it will report financial results for the first quarter 2023 after the market close on Wednesday, April 26, 2023. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.

CONMED Corporation (NYSECNMD) today announced that its Annual Meeting of Stockholders will be held on Wednesday, May 24, 2023, at 1:30 p.m. ET at its corporate headquarters at 11311 Concept Boulevard, Largo FL and through the internet virtually. Shareholders of record at the close of business on March 28, 2023 shall be entitled to vote at the 2023 Annual Meeting.

CONMED Corporation (NYSECNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at the KeyBanc Life Sciences and MedTech Investor Forum at 9:00 a.m. ET on Wednesday, March 22, 2023.

CONMED Corporation (NYSECNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on April 5, 2023, to all shareholders of record as of March 15, 2023.

CONMED Corporation (NYSECNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2022.

CONMED Corporation (NYSECNMD) today announced that it will report financial results for the fourth quarter 2022 after the market close on Thursday, February 2, 2023. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.

CONMED Corporation (NYSECNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on January 5, 2023, to all shareholders of record as of December 16, 2022.

CONMED Corporation (NYSECNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the 34th Annual Piper Sander Healthcare Conference at 3:30 p.m. ET on Wednesday, November 30, 2022.

CONMED Corporation (NYSECNMD) today announced that due to a temporary disruption resulting from the implementation of new warehouse management software, the Company is withdrawing its previously issued full-year 2022 financial outlook.

CONMED Corporation (NYSECNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Stifel 2022 Healthcare Conference at 1:15 p.m. ET on Tuesday, November 15, 2022.

CONMED Corporation (NYSECNMD) today announced financial results for the third quarter ended September 30, 2022.

CONMED Corporation (NYSECNMD) today announced that it will report financial results for the third quarter 2022 after the market close on Wednesday, October 26, 2022. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.

CONMED Corporation (NYSECNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the 20th Annual Morgan Stanley Global Healthcare Conference at 5:15 p.m. ET on Tuesday, September 13, 2022.

CONMED Corporation (NYSECNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on October 5, 2022 to all shareholders of record as of September 15, 2022.

CONMED Corporation (NYSECNMD) today announced that it has completed its previously announced acquisition of privately-held Biorez, Inc.

CONMED Corporation (NYSECNMD) today announced a definitive agreement to acquire privately held Biorez, Inc. (Biorez), on a cash-free, debt-free basis, for cash consideration of $85 million at closing, subject to adjustment, and up to an additional $165 million in growth-based earnout payments over a four-year period. The transaction is expected to be financed through the company's existing credit facility. The transaction is expected to close in early August 2022.

CONMED Corporation (NYSECNMD) today announced financial results for the second quarter ended June 30, 2022.

CONMED Corporation (NYSECNMD) today announced that it will report financial results for the second quarter 2022 after the market close on Wednesday, July 27, 2022. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.

CONMED Corporation (NYSECNMD) today announced that it has completed its previously announced acquisition of privately-held In2Bones Global Inc.

CONMED Corporation (NYSECNMD) today announced the pricing of $700 million aggregate principal amount of 2.25% convertible senior notes due 2027 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). In connection with the offering of the notes, CONMED has granted the initial purchasers an option to purchase, for settlement within a 13-day period beginning on, and including, the first day on which the notes are issued, up to an additional $100 million aggregate principal amount of the notes. The offering of the notes and the convertible note hedge and warrant transactions described below are expected to close on June 6, 2022, subject to customary closing conditions.

CONMED Corporation (NYSECNMD) today announced that it intends to offer, subject to market conditions and other factors, $600 million aggregate principal amount of its convertible senior notes due 2027 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). In connection with the offering of the notes, CONMED expects to grant the initial purchasers an option to purchase, for settlement within a 13-day period beginning on, and including, the first day on which the notes are issued, up to an additional $100 million aggregate principal amount of the notes.

CONMED Corporation (NYSECNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on July 5, 2022 to all shareholders of record as of June 15, 2022.

CONMED Corporation (NYSECNMD) today announced financial results for the first quarter ended March 31, 2022.

CONMED Corporation (NYSECNMD) today announced that it will reschedule the reporting of its first quarter 2022 financial results due to a corporate conflict. The release of these financial results, which was previously scheduled for Wednesday, April 27, 2022, will now take place on Wednesday, May 4, 2022, after the market close. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.

CONMED Corporation (NYSECNMD) today announced that it will report financial results for the first quarter 2022 after the market close on Wednesday, April 27, 2022. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.

CONMED Corporation (NYSECNMD) today announced that its Annual Meeting of Stockholders will be held as a virtual meeting on Wednesday, May 25, 2022, at 1:30 p.m. ET. Shareholders of record at the close of business on April 5, 2022 shall be entitled to vote at the 2022 Annual Meeting.

CONMED Corporation (NYSECNMD) today announced financial results for the fourth quarter and full year ended December 31, 2021.

CONMED Corporation (NYSECNMD) today announced that it will report financial results for the fourth quarter 2021 after the market close on Wednesday, January 26, 2022. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.

CONMED Corporation (NYSECNMD) today announced that Curt R. Hartman, Chair of the Board, President & Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the 40th Annual J.P. Morgan Virtual Healthcare Conference at 9:00 a.m. ET on Monday, January 10, 2022.

CONMED Corporation (NYSECNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on January 5, 2022 to all shareholders of record as of December 15, 2021.

CONMED Corporation (NYSECNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference.

CONMED Corporation (NYSECNMD) today announced Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a presentation at the Stifel 2021 Virtual Healthcare Conference at 2:40 p.m. ET on Tuesday, November 16, 2021.

CONMED Corporation (NYSECNMD) today announced financial results for the third quarter ended September 30, 2021.

CONMED Corporation (NYSECNMD) today announced that it will report financial results for the third quarter 2021 after the market close on October 27, 2021. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.

CONMED Corporation (NYSECNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at the 19th Annual Morgan Stanley Global Healthcare Conference at 5:00 p.m. ET on Tuesday, September 14, 2021.

CONMED Corporation (NYSECNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on October 5, 2021 to all shareholders of record as of September 15, 2021.